Diagnostics | Free Full-Text | Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with
PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract
JCM | Free Full-Text | New Biopsy Techniques and Imaging Features of Transrectal Ultrasound for Targeting PI-RADS 4 and 5 Lesions
Prostate cancer in PI-RADS scores 1 and 2 version 2.1: a comparison to previous PI-RADS versions | SpringerLink
In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied? | Egyptian Journal of Radiology and Nuclear Medicine | Full Text
Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions | Scientific Reports
What is PI-RADS and why should you care? | THE "NEW" PROSTATE CANCER INFOLINK
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology
Cancer detection by PI-RADS score and overall | Download Scientific Diagram
Decision tree for managing PI-RADS 3 lesions in African American men... | Download Scientific Diagram
PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract
PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect
Results from a PI-RADS-based MRI-directed diagnostic pathway for biopsy-naive patients in a non-university hospital | SpringerLink
PI-RADS III (prostate cancer). a Axial T2-WI shows TZ heterogeneous... | Download Scientific Diagram
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology
PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? | Semantic Scholar
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology
The basics of PI-RADS scoring and how AI can help
An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study - The
Prostate Imaging-Reporting and Data System (PI-RADS) | Radiology Reference Article | Radiopaedia.org
Frontiers | New TRUS Techniques and Imaging Features of PI-RADS 4 or 5: Influence on Tumor Targeting
JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
